13D Filing: Care Capital and Minerva Neurosciences, Inc. (NERV)

 

beneficial ownership of the securities and this report shall not be deemed an admission that Care Capital III LLC is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein.

 

(c)                                  During the past sixty days prior to the date hereof, the following transactions occurred:

 

Identity of Person Who Effected the Transaction		Date of Transaction		Amount of Securities Sold		Weighted Average Price Per Share			Where and How Transaction was Effected
Care Capital Investments III L.P.		3/18/2016		10,585		$	6.15		Open Market
Care Capital Offshore Investments III LP		3/18/2016		179		$	6.15		Open Market
Care Capital Investments III L.P.		3/19/2016		476		$	6.12		Open Market
Care Capital Offshore Investments III LP		3/19/2016		8		$	6.12		Open Market
Care Capital Investments III L.P.		3/22/2016		36,985		$	6.21		Open Market
Care Capital Offshore Investments III LP		3/22/2016		618		$	6.21		Open Market
Care Capital Investments III L.P.		3/24/2016		6,885		$	6.07		Open Market
Care Capital Offshore Investments III LP		3/24/2016		115		$	6.07		Open Market

 

(d)                                 No person, other than Care Capital III LLC, is known to have the right to receive or the power to direct the receipt of dividends from, or any proceeds from the sale of, the shares of Common Stock beneficially owned by each of Care Capital Investments III L.P. and Care Capital Offshore Investments III LP.

 

(e)                                  Not applicable.

 

6